Verition Fund Management LLC Athira Pharma, Inc. Transaction History

Verition Fund Management LLC

  • $17.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
SELL
$1.9 - $3.16 $21,515 - $35,783
-11,324 Reduced 10.17%
100,000 $202,000
Q2 2023

Aug 14, 2023
BUY
$2.36 - $3.59 $262,724 - $399,653
111,324 New
111,324 $328,000
Q1 2022

May 13, 2022
SELL
$8.96 - $13.51 $884,002 - $1.33 Million
-98,661 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$9.17 - $16.39 $904,721 - $1.62 Million
98,661 New
98,661 $1.29 Million

Others Institutions Holding ATHA

# of Institutions
66
Shares Held
16.9M
Call Options Held
112K
Put Options Held
68K
View Full List

About Athira Pharma, Inc.

ATHA Quotes by TradingView
  • Ticker ATHA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,817,700
  • Market Cap $23.4M
  • Description
  • Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...
More about ATHA
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email